| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |